These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 20074261)

  • 1. The interrelationship of complement-activation fragments and angiogenesis-related factors in early pregnancy and their association with pre-eclampsia.
    Lynch AM; Murphy JR; Gibbs RS; Levine RJ; Giclas PC; Salmon JE; Holers VM
    BJOG; 2010 Mar; 117(4):456-62. PubMed ID: 20074261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of anti-hypertensive drugs on production of soluble fms-like tyrosine kinase 1 and soluble endoglin from human normal and pre-eclamptic placentas in vitro.
    Xu B; Thornton C; Tooher J; Ogle R; Lim S; Makris A; Hennessy A
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):839-42. PubMed ID: 19215236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis.
    Kleinrouweler CE; Wiegerinck MM; Ris-Stalpers C; Bossuyt PM; van der Post JA; von Dadelszen P; Mol BW; Pajkrt E;
    BJOG; 2012 Jun; 119(7):778-87. PubMed ID: 22433027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure to up-regulate VEGF165b in maternal plasma is a first trimester predictive marker for pre-eclampsia.
    Bills VL; Varet J; Millar A; Harper SJ; Soothill PW; Bates DO
    Clin Sci (Lond); 2009 Feb; 116(3):265-72. PubMed ID: 18826376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia.
    De Vivo A; Baviera G; Giordano D; Todarello G; Corrado F; D'anna R
    Acta Obstet Gynecol Scand; 2008; 87(8):837-42. PubMed ID: 18607829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
    Aggarwal PK; Chandel N; Jain V; Jha V
    J Hum Hypertens; 2012 Apr; 26(4):236-41. PubMed ID: 21451568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of urinary soluble endoglin in the diagnosis of pre-eclampsia: comparison with soluble fms-like tyrosine kinase 1 to placental growth factor ratio.
    Buhimschi CS; Baumbusch MA; Dulay AT; Lee S; Wehrum M; Zhao G; Bahtiyar MO; Pettker CM; Ali UA; Funai EF; Buhimschi IA
    BJOG; 2010 Feb; 117(3):321-30. PubMed ID: 19943826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placental lesions and differential expression of pro-and anti-angiogenic growth mediators and oxidative DNA damage marker in placentae of Ghanaian suboptimal and optimal health status pregnant women who later developed preeclampsia.
    Anto EO; Coall DA; Asiamah EA; Afriyie OO; Addai-Mensah O; Wiafe YA; Owiredu W; Obirikorang C; Annani-Akollor ME; Titiloye NA; Adua E; Acheampong E; Adu EA; Opoku S; Anto AO; Tawiah A; Wang Y; Wang W
    PLoS One; 2022; 17(3):e0265717. PubMed ID: 35312727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.
    Chaiworapongsa T; Romero R; Whitten AE; Korzeniewski SJ; Chaemsaithong P; Hernandez-Andrade E; Yeo L; Hassan SS
    J Matern Fetal Neonatal Med; 2016; 29(8):1214-28. PubMed ID: 26303962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.
    Lim JH; Kim SY; Park SY; Yang JH; Kim MY; Ryu HM
    Obstet Gynecol; 2008 Jun; 111(6):1403-9. PubMed ID: 18515525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal imbalance between pro-angiogenic and anti-angiogenic factors in HIV-infected women with pre-eclampsia.
    Govender N; Naicker T; Moodley J
    Cardiovasc J Afr; 2013 Jun; 24(5):174-9. PubMed ID: 24217170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble endoglin (sEng) joins the soluble fms-like tyrosine kinase (sFlt) receptor as a pre-eclampsia molecule.
    Luft FC
    Nephrol Dial Transplant; 2006 Nov; 21(11):3052-4. PubMed ID: 16870672
    [No Abstract]   [Full Text] [Related]  

  • 13. Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia.
    Reddy A; Suri S; Sargent IL; Redman CW; Muttukrishna S
    PLoS One; 2009; 4(2):e4453. PubMed ID: 19412349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
    Govender N; Naicker T; Rajakumar A; Moodley J
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study.
    Myers JE; Kenny LC; McCowan LM; Chan EH; Dekker GA; Poston L; Simpson NA; North RA;
    BJOG; 2013 Sep; 120(10):1215-23. PubMed ID: 23906160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between circulating tissue transglutaminase, soluble fms-like tyrosine kinase-1, soluble endoglin and vascular endothelial growth factor in pre-eclampsia.
    Cheng M; He P; Fu J
    J Hum Hypertens; 2016 Dec; 30(12):788-793. PubMed ID: 27169826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenic profile in the Finnish Genetics of Pre-Eclampsia Consortium (FINNPEC) cohort.
    Jääskeläinen T; Heinonen S; Hämäläinen E; Pulkki K; Romppanen J; Laivuori H;
    Pregnancy Hypertens; 2018 Oct; 14():252-259. PubMed ID: 29803331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.
    Tong S; Kaitu'u-Lino TJ; Onda K; Beard S; Hastie R; Binder NK; Cluver C; Tuohey L; Whitehead C; Brownfoot F; De Silva M; Hannan NJ
    Hypertension; 2015 Nov; 66(5):1073-81. PubMed ID: 26324507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antihypertensive therapy with alpha methyldopa on levels of angiogenic factors in pregnancies with hypertensive disorders.
    Khalil A; Muttukrishna S; Harrington K; Jauniaux E
    PLoS One; 2008 Jul; 3(7):e2766. PubMed ID: 18648513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New insights into the pathogenesis of pre-eclampsia: the role of angiogenesis-inhibiting factors].
    Verdonk K; Visser W; Steegers EA; Kappers M; Danser AH; van den Meiracker AH
    Ned Tijdschr Geneeskd; 2011; 155():A2946. PubMed ID: 21486506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.